DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 97 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $31,096,000 | -41.8% | 1,542,476 | +7.8% | 0.00% | -33.3% |
| Q2 2021 | $53,425,000 | +102.1% | 1,431,526 | +38.5% | 0.01% | +50.0% |
| Q1 2021 | $26,430,000 | +50.1% | 1,033,624 | +29.3% | 0.00% | +33.3% |
| Q4 2020 | $17,610,000 | +61.5% | 799,309 | +34.8% | 0.00% | +50.0% |
| Q3 2020 | $10,907,000 | -16.1% | 593,138 | +15.9% | 0.00% | -33.3% |
| Q2 2020 | $12,997,000 | +54.8% | 511,689 | +11.9% | 0.00% | +50.0% |
| Q1 2020 | $8,398,000 | -32.5% | 457,106 | -19.1% | 0.00% | 0.0% |
| Q4 2019 | $12,445,000 | +85.5% | 564,911 | +20.9% | 0.00% | +100.0% |
| Q3 2019 | $6,710,000 | -10.7% | 467,289 | -2.1% | 0.00% | 0.0% |
| Q2 2019 | $7,518,000 | +15.1% | 477,324 | +7.1% | 0.00% | 0.0% |
| Q1 2019 | $6,530,000 | +4342.2% | 445,722 | +3144.4% | 0.00% | – |
| Q4 2018 | $147,000 | -83.7% | 13,738 | -76.7% | 0.00% | – |
| Q3 2018 | $900,000 | +42.0% | 59,018 | +14.0% | 0.00% | – |
| Q2 2018 | $634,000 | -45.2% | 51,780 | -57.2% | 0.00% | – |
| Q1 2018 | $1,156,000 | +261.2% | 120,948 | +241.4% | 0.00% | – |
| Q4 2017 | $320,000 | +3900.0% | 35,423 | +2113.9% | 0.00% | – |
| Q3 2017 | $8,000 | -27.3% | 1,600 | -52.5% | 0.00% | – |
| Q2 2017 | $11,000 | +57.1% | 3,370 | +60.5% | 0.00% | – |
| Q1 2017 | $7,000 | -91.0% | 2,100 | -84.2% | 0.00% | – |
| Q3 2016 | $78,000 | +30.0% | 13,278 | -34.1% | 0.00% | – |
| Q2 2016 | $60,000 | -91.0% | 20,142 | -83.8% | 0.00% | – |
| Q1 2016 | $669,000 | -55.8% | 124,700 | -2.3% | 0.00% | – |
| Q4 2015 | $1,514,000 | +33.2% | 127,625 | -7.8% | 0.00% | – |
| Q3 2015 | $1,137,000 | -47.6% | 138,475 | -11.0% | 0.00% | -100.0% |
| Q2 2015 | $2,171,000 | -58.0% | 155,650 | -27.7% | 0.00% | 0.0% |
| Q1 2015 | $5,173,000 | +3.5% | 215,275 | -29.1% | 0.00% | 0.0% |
| Q4 2014 | $5,000,000 | +11.9% | 303,625 | -13.5% | 0.00% | 0.0% |
| Q3 2014 | $4,468,000 | -44.3% | 350,950 | -1.3% | 0.00% | -50.0% |
| Q2 2014 | $8,026,000 | +8.0% | 355,575 | +35.1% | 0.00% | 0.0% |
| Q1 2014 | $7,433,000 | – | 263,125 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 4,080,237 | $103,638,000 | 10.86% |
| Aquilo Capital Management, LLC | 1,454,686 | $36,949,000 | 7.45% |
| RTW INVESTMENTS, LP | 7,152,918 | $181,684,000 | 5.11% |
| EcoR1 Capital, LLC | 2,721,993 | $69,139,000 | 5.11% |
| BRIDGER MANAGEMENT, LLC | 1,473,568 | $37,429,000 | 3.47% |
| DAFNA Capital Management LLC | 454,236 | $11,538,000 | 3.33% |
| Parkman Healthcare Partners LLC | 300,805 | $7,640,000 | 2.15% |
| ACUTA CAPITAL PARTNERS, LLC | 170,000 | $4,318,000 | 1.25% |
| Integral Health Asset Management, LLC | 110,000 | $2,794,000 | 0.84% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,013,087 | $25,732,000 | 0.63% |